Arrowhead, Novartis in up to $2 billion deal for neuromuscular therapy license
(Reuters) -Arrowhead Pharmaceuticals said on Tuesday it will receive up to $2 billion from Novartis...
2nd September, 2025
(Reuters) -Arrowhead Pharmaceuticals said on Tuesday it will receive up to $2 billion from Novartis...
2nd September, 2025
(Reuters) -Broadwood Partners, the largest shareholder of STAAR Surgical, said on Tuesday it intende...
2nd September, 2025
By Javi West Larrañaga and Mireia Merino (Reuters) -Spanish travel company eDreams ODIGEO has withdr...
2nd September, 2025
By John Revill and Emma-Victoria Farr ZURICH (Reuters) -Online classifieds business Swiss Marketplac...
2nd September, 2025
By Javi West Larrañaga and Mireia Merino (Reuters) -Shares of Spanish travel booking company eDreams...
2nd September, 2025
(Corrects name of partner and chairman to Giuseppe Ciucci in paragraph 6, NOT Tony Ciucci.) By Hadee...
2nd September, 2025
By Emily Rose, Maayan Lubell and Nidal al-Mughrabi JERUSALEM/CAIRO (Reuters) -Tens of thousands of r...
2nd September, 2025
(Reuters) -Ithaca Energy shares fell nearly 17% on Tuesday after its two largest shareholders sold a...
2nd September, 2025
(Reuters) -British fibre broadband network CityFibre's founder and Chief Executive Officer Greg Mesc...
2nd September, 2025
(Reuters) -Brazilian goalkeeper Ederson has completed a permanent transfer to Turkish side Fenerbahc...
2nd September, 2025
(Reuters) -German engine maker Deutz said on Tuesday that it will acquire Sobek Group, a manufacture...
2nd September, 2025
LONDON (Reuters) -British lender Shawbrook said on Tuesday it had reached an agreement to buy specia...
2nd September, 2025